| Literature DB >> 26684627 |
S Cantore1, A Ballini2, D Farronato3, G Malcangi4, G Dipalma4, F Assandri5, U Garagiola5, F Inchingolo4, D De Vito1, N Cirulli1.
Abstract
Obstructive sleep apnea syndrome (OSAS) is a phenomenon of repeated, episodic reduction, or cessation of airflow (hypopnea/apnea) as a result of upper airways obstruction. First-line treatment in younger children is adenotonsillectomy, although other available treatment options in middle-aged adults include continuous positive airways pressure (CPAP) and airway adjuncts. Oral appliances (OA) are a viable treatment alternative in patients with OSAS.The objective of this study was to assess, in a 1-year follow-up study, an OA in OSAS patients. The participants were subjected to polysomnographic examination with a validated device (MicroMESAM). Eight participants were fitted with a Thornton Adjustable Positioner (TAP). The participants were asked to wear the test appliance for 7 nights, and in case of compliance, for 6 months. The selected patients record their usage of the appliance and any adverse effects in a treatment journal. The research focused on the following outcomes: sleep apnea (i.e. reduction in the apnea/hypopnea index) and the effect of oral appliances on daytime function.In conclusion, the results suggest that OA have a definite role in the treatment of snoring and sleep apnea.Entities:
Keywords: Thornton Adjustable Positioner; apnea-hypopnea index; continuous positive airway pressure; obstructive sleep apnea syndrome; oral appliance
Mesh:
Year: 2015 PMID: 26684627 PMCID: PMC5806714 DOI: 10.1177/0394632015590949
Source DB: PubMed Journal: Int J Immunopathol Pharmacol ISSN: 0394-6320 Impact factor: 3.219